Cargando…
Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328008/ https://www.ncbi.nlm.nih.gov/pubmed/32609812 http://dx.doi.org/10.1093/neuonc/noaa115 |
| _version_ | 1783732223265996800 |
|---|---|
| author | van den Bent, Martin Eoli, Marica Sepulveda, Juan Manuel Smits, Marion Walenkamp, Annemiek Frenel, Jean-Sebastian Franceschi, Enrico Clement, Paul M Chinot, Olivier de Vos, Filip Whenham, Nicolas Sanghera, Paul Weller, Michael Dubbink, H J French, Pim Looman, Jim Dey, Jyotirmoy Krause, Scott Ansell, Pete Nuyens, Sarah Spruyt, Maarten Brilhante, Joana Coens, Corneel Gorlia, Thierry Golfinopoulos, Vassilis |
| author_facet | van den Bent, Martin Eoli, Marica Sepulveda, Juan Manuel Smits, Marion Walenkamp, Annemiek Frenel, Jean-Sebastian Franceschi, Enrico Clement, Paul M Chinot, Olivier de Vos, Filip Whenham, Nicolas Sanghera, Paul Weller, Michael Dubbink, H J French, Pim Looman, Jim Dey, Jyotirmoy Krause, Scott Ansell, Pete Nuyens, Sarah Spruyt, Maarten Brilhante, Joana Coens, Corneel Gorlia, Thierry Golfinopoulos, Vassilis |
| author_sort | van den Bent, Martin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8328008 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83280082021-08-03 Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma van den Bent, Martin Eoli, Marica Sepulveda, Juan Manuel Smits, Marion Walenkamp, Annemiek Frenel, Jean-Sebastian Franceschi, Enrico Clement, Paul M Chinot, Olivier de Vos, Filip Whenham, Nicolas Sanghera, Paul Weller, Michael Dubbink, H J French, Pim Looman, Jim Dey, Jyotirmoy Krause, Scott Ansell, Pete Nuyens, Sarah Spruyt, Maarten Brilhante, Joana Coens, Corneel Gorlia, Thierry Golfinopoulos, Vassilis Neuro Oncol Corrigenda Oxford University Press 2020-07-01 /pmc/articles/PMC8328008/ /pubmed/32609812 http://dx.doi.org/10.1093/neuonc/noaa115 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Corrigenda van den Bent, Martin Eoli, Marica Sepulveda, Juan Manuel Smits, Marion Walenkamp, Annemiek Frenel, Jean-Sebastian Franceschi, Enrico Clement, Paul M Chinot, Olivier de Vos, Filip Whenham, Nicolas Sanghera, Paul Weller, Michael Dubbink, H J French, Pim Looman, Jim Dey, Jyotirmoy Krause, Scott Ansell, Pete Nuyens, Sarah Spruyt, Maarten Brilhante, Joana Coens, Corneel Gorlia, Thierry Golfinopoulos, Vassilis Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma |
| title | Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma |
| title_full | Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma |
| title_fullStr | Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma |
| title_full_unstemmed | Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma |
| title_short | Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma |
| title_sort | corrigendum to intellance 2/eortc 1410 randomized phase ii study of depatux-m alone and with temozolomide vs temozolomide or lomustine in recurrent egfr amplified glioblastoma |
| topic | Corrigenda |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328008/ https://www.ncbi.nlm.nih.gov/pubmed/32609812 http://dx.doi.org/10.1093/neuonc/noaa115 |
| work_keys_str_mv | AT vandenbentmartin corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT eolimarica corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT sepulvedajuanmanuel corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT smitsmarion corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT walenkampannemiek corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT freneljeansebastian corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT franceschienrico corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT clementpaulm corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT chinotolivier corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT devosfilip corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT whenhamnicolas corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT sangherapaul corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT wellermichael corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT dubbinkhj corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT frenchpim corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT loomanjim corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT deyjyotirmoy corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT krausescott corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT ansellpete corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT nuyenssarah corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT spruytmaarten corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT brilhantejoana corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT coenscorneel corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT gorliathierry corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma AT golfinopoulosvassilis corrigendumtointellance2eortc1410randomizedphaseiistudyofdepatuxmaloneandwithtemozolomidevstemozolomideorlomustineinrecurrentegframplifiedglioblastoma |